世界中医药
文章摘要
引用本文:王连心1 谢雁鸣1 常艳鹏1,2 易丹辉3.主动监测在中药注射剂上市后临床安全性评价的应用及范例[J].世界中医药,2014,9(09):.  
主动监测在中药注射剂上市后临床安全性评价的应用及范例
Clinical Application and Example of Active Post-marketing Safety Surveillance of Traditional Chinese Medicine
投稿时间:2014-08-06  
DOI:10.3969/j.issn.1673-7202.2014.09.006
中文关键词:  中药注射剂  安全性  主动监测  巢式病例对照  真实世界
English Keywords:TCM injections  Safety  Active Surveillance  Nested case-control design  Real world
基金项目:国家中医药管理局中医药行业科研专项资助项目(编号:200907001-5-6);“重大新药创制”科技重大专项“中药上市后再评价关键技术研究”(编号:2009ZX09502-030);中国中医科学院科技创新团队建设项目(编号:PY1303)
作者单位
王连心1 谢雁鸣1 常艳鹏1,2 易丹辉3 1 中国中医科学院中医临床基础医学研究所北京100700 2 沈阳市骨科医院沈阳110044 3 中国人民大学北京100872 
摘要点击次数: 1319
全文下载次数: 1698
中文摘要:
      目的:以三种清热解毒类中药注射剂为例,为其上市后临床安全性评价及方法学研究提供范例。方法:基于前瞻性、多中心、大样本主动监测嵌套巢式病例对照设计的方法,监测使用三种中药注射剂的患者,探索不良反应发生率、发生特征及过敏反应可能的影响因素。结果:监测10 029例患者,共发生26例ADR,包括5例过敏反应,经过人体免疫毒理学指标检测,患者的IgE皆有所升高。结论:基于监测数据计算总体ADR发生率为0.26%,属于偶见(0.1%~1%),过敏反应可能由IgE介导,这也为此类问题的研究探索了方法学范式。
English Summary:
      To explore and evaluate the post-marketing safety evaluation methods with the example of three heat-clearing and detoxifying injections of traditional Chinese medicine.Methods:We monitored patients taken the above injections based on active surveillance methods. It is a prospective, multi-center, large sample and nested case-controlled design, to investigate the incidence, characteristics and influencing factors of adverse reaction (ADR). Results:Among 10,029 patients monitored, 26 patients had ADR, 5 of them experienced allergic reactions. IgE of the 5 patients who had allergic reactions was elevated. Conclusion: The overall ADR incidence rate is 0.26% (0.1% ~ 1%) and allergic reactions are probably mediated by IgE.
查看全文  查看/发表评论  下载PDF阅读器